211 related articles for article (PubMed ID: 11463377)
1. Cooperation between STAT3 and c-jun suppresses Fas transcription.
Ivanov VN; Bhoumik A; Krasilnikov M; Raz R; Owen-Schaub LB; Levy D; Horvath CM; Ronai Z
Mol Cell; 2001 Mar; 7(3):517-28. PubMed ID: 11463377
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling.
Ivanov VN; Krasilnikov M; Ronai Z
J Biol Chem; 2002 Feb; 277(7):4932-44. PubMed ID: 11733515
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.
Leu JI; Crissey MA; Leu JP; Ciliberto G; Taub R
Mol Cell Biol; 2001 Jan; 21(2):414-24. PubMed ID: 11134330
[TBL] [Abstract][Full Text] [Related]
4. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE).
Schuringa JJ; Timmer H; Luttickhuizen D; Vellenga E; Kruijer W
Cytokine; 2001 Apr; 14(2):78-87. PubMed ID: 11356008
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
Yoo YG; Lee MO
J Biol Chem; 2004 Aug; 279(35):36242-9. PubMed ID: 15173177
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter.
Yoo JY; Wang W; Desiderio S; Nathans D
J Biol Chem; 2001 Jul; 276(28):26421-9. PubMed ID: 11319221
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence.
Shiozawa T; Miyamoto T; Kashima H; Nakayama K; Nikaido T; Konishi I
Oncogene; 2004 Nov; 23(53):8603-10. PubMed ID: 15467760
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors.
Lasham A; Lindridge E; Rudert F; Onrust R; Watson J
Gene; 2000 Jul; 252(1-2):1-13. PubMed ID: 10903433
[TBL] [Abstract][Full Text] [Related]
9. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
Bousquet C; Zatelli MC; Melmed S
J Clin Invest; 2000 Dec; 106(11):1417-25. PubMed ID: 11104795
[TBL] [Abstract][Full Text] [Related]
10. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells.
Boehlk S; Fessele S; Mojaat A; Miyamoto NG; Werner T; Nelson EL; Schlöndorff D; Nelson PJ
Eur J Immunol; 2000 Apr; 30(4):1102-12. PubMed ID: 10760799
[TBL] [Abstract][Full Text] [Related]
11. c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents.
Kolbus A; Herr I; Schreiber M; Debatin KM; Wagner EF; Angel P
Mol Cell Biol; 2000 Jan; 20(2):575-82. PubMed ID: 10611236
[TBL] [Abstract][Full Text] [Related]
12. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.
Eichhorst ST; Müller M; Li-Weber M; Schulze-Bergkamen H; Angel P; Krammer PH
Mol Cell Biol; 2000 Oct; 20(20):7826-37. PubMed ID: 11003676
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide inhibits the transcription repressor Yin-Yang 1 binding activity at the silencer region of the Fas promoter: a pivotal role for nitric oxide in the up-regulation of Fas gene expression in human tumor cells.
Garbán HJ; Bonavida B
J Immunol; 2001 Jul; 167(1):75-81. PubMed ID: 11418634
[TBL] [Abstract][Full Text] [Related]
14. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3.
Schaefer TS; Sanders LK; Nathans D
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9097-101. PubMed ID: 7568080
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of Fas/FasL-mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c-Jun activation in HL-60 leukemia cells.
Wang SW; Chen YR; Chow JM; Chien MH; Yang SF; Wen YC; Lee WJ; Tseng TH
Mol Carcinog; 2018 Jul; 57(7):866-877. PubMed ID: 29566277
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
18. HMG-I/Y is a c-Jun/activator protein-1 target gene and is necessary for c-Jun-induced anchorage-independent growth in Rat1a cells.
Hommura F; Katabami M; Leaner VD; Donninger H; Sumter TF; Resar LM; Birrer MJ
Mol Cancer Res; 2004 May; 2(5):305-14. PubMed ID: 15192124
[TBL] [Abstract][Full Text] [Related]
19. Androgen and the blocking of radiation-induced sensitization to Fas-mediated apoptosis through c-jun induction in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Konishi N
Int J Radiat Biol; 2003 Jun; 79(6):451-62. PubMed ID: 12963547
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B-dependent Fas ligand expression.
Hsu SC; Gavrilin MA; Lee HH; Wu CC; Han SH; Lai MZ
Eur J Immunol; 1999 Sep; 29(9):2948-56. PubMed ID: 10508269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
